Overview
The Centre for Medicinal Chemistry and Pharmacology (CMCP) was established in November 2006 and involves 11 academic staff and 10 additional post-doctoral researchers. This research centre endeavours to enhance the understanding of the molecular origins of disease and undertake modern drug design, leading to the development of new pharmaceuticals. The three major disease states currently being targeted by the CMCP are: anti-infectives, encompassing antibacterial agents, including multi-drug resistant strains, anti-viral agents (e.g. HIV, Dengue fever, hepatitis C, anti-fungals) and anti-malarial agents; anti-cancer agents, incorporating both drug design and development as well as formulation and clinical aspects; and cardio-vascular disease, including fundamental research associated with phospholipids and diet as well as the development of new small molecule therapeutics. The director of the CMCP is Assoc. Prof. Paul Keller.
|